Overview

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arizona
Treatments:
Tamsulosin